Home › Neuromyelitis Optica › Massachusetts
Neuromyelitis Optica clinical trials in Massachusetts
5 studies for Neuromyelitis Optica are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Research Site, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT05966467Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Research Site, Boston
RecruitingObservational study
All ages · Women · Updated Apr 16, 2026 · NCT06312644Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Dec 5, 2025 · NCT05549258Efgartigimod for the Treatment of Acute Optic Neuritis
- Massachusetts Eye and Ear Infirmary, Boston
- Massachusetts General Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT06453694Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- Massachussets General Hospital, Boston
Recruiting
Ages 18 and older · All sexes · Updated Apr 10, 2025 · NCT05566769From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.